You are here

Article Text

Article menu

Download PDFPDF

Editor’s quiz: GI snapshot
Jejunal perforation and central retinal vein occlusion in a 55-year-old European man
Free
  1. Amanda Louise Thomas1,
  2. Luke Summers1,
  3. James R Goodhand1,2,
  4. Sarah Saunders3
  1. 1 Gastroenterology, Royal Devon and Exeter Hospital, Exeter, UK
  2. 2 Gastroenterology, Royal Free Hospital, London, UK
  3. 3 Histopathology Department, Royal Devon and Exeter Hospital, Exeter, UK
  1. Correspondence to Dr Sarah Saunders; ssaunders4{at}nhs.net

https://doi.org/10.1136/gutjnl-2019-318342

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Clinical presentation

    A 53-year-old white European male builder presented emergently with haematemesis and melaena. Four months previously, he underwent an exploratory laparotomy, small bowel resection and anastomosis for a spontaneous jejunal perforation. His immediate postoperative course was uneventful. One month prior to this admission he lost the sight in his right eye because of a central retinal vein occlusion (CRVO): blood cultures, vasculitis and thrombophilia screens were negative and an echocardiogram and carotid Dopplers unremarkable. There was no significant family history. For the treatment of his CRVO, he was taking 15 mg of prednisolone daily and 150 mg of aspirin. He consumed 14 units of alcohol per week but did not smoke cigarettes.

    Initial laboratory tests showed haemoglobin 103 g/L (normal range 130–180), mean corpuscular volume 97.6 fL (82–98) and lymphopenia 0.80×109/L (1.1–3.5). Tissue transglutaminase antibodies were 1.2 U/mL (0–10.0) with normal IgA levels and antiendomysial antibodies were negative.

    Oesophagogastroduodenoscopy demonstrated a duodenal ulcer with a bleeding vessel that was clipped and injected with epinephrine. Four days later, however, he developed peritonitis that required an emergency laparotomy and small bowel resection (see figures 1–3).

    Question

    What was the diagnosis?

    Figure 1
    Figure 1

    Macroscopic appearance of the small bowel.

    Figure 2
    Figure 2

    H&E ×10 of small bowel mucosa.

    Figure 3
    Figure 3

    H&E ×40 of small bowel mucosa.

    Answer

    The small bowel macroscopically was thickened and oedematous with multiple perforations and abundant serosal exudate. The mucosa showed blunting of the intestinal villi with intraepithelial lymphocytosis (see figures 4 and 5): the immunophenotype was characteristic for type 1 refractory coeliac disease. A population of neoplastic T lymphocytes with a clonal cytotoxic immunophenotype were seen to invade the lamina propria indicating enteropathy-associated T cell lymphoma.

    Figure 4
    Figure 4

    H&E ×10 showing areas of mucosa ulceration and wall of the perforation site with florid acute inflammation.

    Figure 5
    Figure 5

    H&E ×20 showing diffuse infiltration by a population of blasts with abundant apoptotic debris.

    About one-third of patients diagnosed with small bowel lymphoma have evidence of proximal villous atrophy.1 Our patient was seronegative but carried the coeliac risk-serotype HLA-DQ2. Seronegative coeliac disease is rare among patients with coeliac disease but is a common cause of seronegative villous atrophy and is associated with high mortality.2 3 Enteropathy-associated T cell lymphoma is a rare form of extranodal T cell lymphoma that is usually, but not always, associated with untreated or undiagnosed coeliac disease.4 Patients are typically diagnosed in the sixth or seventh decade of life and are more often male. The jejunum is the most commonly affected part of the GI tract and the diagnosis is frequently made because of stricturing or perforation.4 The prognosis is poor: the estimated overall and treatment failure-free survival at 5 years is 20% and 4%, respectively.5

    References

    1. ↵
      2. Johnston SD ,
      3. Watson RG
      . Small bowel lymphoma in unrecognized coeliac disease: a cause for concern? Eur J Gastroenterol Hepatol 2000;12:645–8.
      OpenUrlCrossRefPubMedWeb of Science
    2. ↵
      2. Schiepatti A ,
      3. Biagi F ,
      4. Fraternale G , et al
      . Short article. Eur J Gastroenterol Hepatol 2017;29:572–6.doi:10.1097/MEG.0000000000000836
      OpenUrl
    3. ↵
      2. Schiepatti A ,
      3. Sanders DS ,
      4. Biagi F
      . Seronegative coeliac disease: clearing the diagnostic dilemma. Curr Opin Gastroenterol 2018;34:154–8.doi:10.1097/MOG.0000000000000436
      OpenUrl
    4. ↵
      2. Swerdlow SH ,
      3. Campo E ,
      4. Pileri SA , et al
      . The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375–90.doi:10.1182/blood-2016-01-643569
      OpenUrlAbstract/FREE Full Text
    5. ↵
      2. Delabie J ,
      3. Holte H ,
      4. Vose JM , et al
      . Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 2011;118:148–55.doi:10.1182/blood-2011-02-335216
      OpenUrlAbstract/FREE Full Text

    Footnotes

    • Contributors All authors were responsible to writing and reviewing final versions of the article. All were in agreement at submission.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Collaborators N A Kennedy.

    • Correction notice This article has been corrected since it published Online First. The second author’s name has been corrected.

    • Patient consent for publication Obtained.